Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Pharmaceutical Technology5h
RFK Jr. trumps domestic manufacturing agenda Day 2 of confirmation hearings
During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...
Trump tariffs on Canadian lumber could be a 'nightmare' for California's fire recovery
U.S. lumber market could see higher prices within a month: analyst The U.S. construction industry may face higher lumber prices within a month if President Donald Trump follows through with his threat ...
Elon Musk Wants Manufacturing to Be 'Cool'—And Snag Smart People From Law and Finance
Manufacturing needs to be "cool" again, attracting more of the talent that flocks to finance and law, Tesla CEO Elon Musk said Wednesday. College graduates have been sending more applications to ...
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...
Eli Lilly's SWOT analysis: stock soars on GLP-1 success, faces competition challenges
Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...
Novo Nordisk's SWOT analysis: stock outlook amid GLP-1 market growth
A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...